Chronic lung conditions such as chronic obstructive pulmonary disease (COPD) and pulmonary hypertension can lead to a serious condition known as pulmonary heart diseases. When the blood vessels in the lungs become damaged or narrowed, the right side of the heart faces increased pressure, leading to strain and enlargement of the heart’s right ventricle. Over time, this can result in right heart failure. Pulmonary heart diseases often go unnoticed in the early stages, but with appropriate treatment, such as oxygen therapy, medications to reduce lung pressures, and lifestyle modifications, patients can manage their condition effectively. Addressing the root cause—often the underlying lung disease—remains crucial in improving outcomes.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China